Navigation Links
Research casts doubt on circulating stem cells

Adult stem cells taken from bone marrow are the "shooting stars" of their field. Many research scientists have been speculating that the cells might be able to pass through the blood into diseased organs and replace defective tissue. Such cells are seen as the potential key to the treatment of certain muscle diseases. However, a study currently being conducted at Bonn's University Clinic has produced some sobering findings: although the cells are able to migrate into the muscle fibres, they do not generally take on any tissue-specific functions.

This, according to the Bonn medical scientists, means the cells would not serve as a substitute for defective muscle cells. The study is reported on 1st August in the online section of the science journal PNAS (www.pnas.org , PNAS Early Edition).

Bone marrow constantly produces stem cells from which, among other things, the white and red blood corpuscles are formed. The dream of many scientists is to breed other types of tissue from bone marrow-derived cells. In recent years a great deal of hype has been generated around the idea of a "cellular jack of all trades" ?not least because some studies gave grounds for hope. Using irradiation techniques, researchers managed to destroy the bone marrow in mice and replace it with cells which became green-fluorescent thanks to a genetic addition. A short time later they then discovered green-fluorescent nerve cells in the mice's brains. This appeared to them to be evidence that the stem cells circulating in the blood could actually transform themselves into nerve tissue. It looked like the discovery of a completely new mechanism: the repairing of tissue using stem cells from the blood stream.

What excited medical scientists most was the idea that the body had at its disposal a kind of "mobile task force" of repair cells, constantly moving through the body and replacing damaged tissue. Even severe diseases like Duchenne muscular dystrophy (DMD), which destroys al l the body's muscles, appeared to be potentially treatable ?indeed, by the simple means of transplanting healthy bone marrow. For boys, DMD is the second most common hereditary disease. Due to a genetic defect, the muscles fail to produce properly functioning dystrophin, an important muscle protein. Those affected develop progressive muscle wasting. They only have a life expectancy of 15 to 20 years.

"In mice with DMD we have replaced the bone marrow with healthy marrow marked by a fluorescent gene," explains Bonn physiologist Professor Dr. Anton Wernig. The hope of the medical scientists is that the transplanted stem cells will find their way through the blood into damaged muscle fibres where they can produce functioning dystrophin. The Bonn researcher team was in fact able to detect green-fluorescent stem cell nuclei in the muscle fibre for several months after the bone marrow transplantation. And, as Professor Wernig emphasises, "they were found in numbers that would have had to bring a significant improvement to the condition of the muscle." The next step was to find out whether the stem cell nuclei were actually producing muscle proteins. Here, the results were negative: "If at all, very few nuclei produced dystrophin ?in any case, far too few to achieve any improvement in the condition." The physiologist concludes, "Although the cells do merge with the defective muscle, we suspect that they remain silent and cannot set off the hoped-for 'muscle programme'." In other words, the bone marrow-derived cells are not converted into functioning muscle fibre.

The myth of a circulating jack of all trades

The reason is probably that in nearly all cells released into the blood from bone marrow many genes are permanently "switched off" and the cells cannot simply be switched back on again. After all, what comes from bone marrow is generally blood and not muscle tissue. The story of a "jack of all trades" circulating via the blood stream throughout t he body and repairing, wherever needed, any type of tissue is, unfortunately, a myth. In practice their impact is, at best, minimal.

The somatic cells mark genetic traits believe by the body to be no longer needed by sticking a label on them ?a sort of molecular "Don't use!" sign. "We have tried to remove this label by chemical means, too, in an effort to get the nuclei of the bone marrow-derived cells to start producing muscle proteins again," says Professor Wernig. "While we were able to activate dystrophin production in the muscle, the effect was nowhere near the level needed to combat the disease. But we shall continue working on this and try to awaken those 'sleeping beauties', the nuclei."

The Bonn physiologist believes that it is necessary to dampen the very high expectations held by some colleagues: "In my view, many of the studies using bone marrow-derived stem cells have so far been interpreted over-optimistically." The experiments with green-fluorescent nerve cells would seem to be one such case: "The bone marrow-derived cells have probably migrated from the blood into the brain where they do not change into nerve cells but blend with the neurones that already exist there." In this case, the presumed stem cells would only have coloured a few brain cells green.


'"/>

Source:University of Bonn


Related biology news :

1. Researchers discover way to make cells in the eye sensitive to light
2. Quantum Dots Research Leads to New Knowledge about Protein Binding in Plants
3. Researchers find how protein allows insects to detect and respond to pheromones
4. Researchers Uncover Key Step In Manufacture of Memory Protein
5. Research advances quest for HIV-1 vaccine
6. Research on Worms Yields Clues on Aging
7. Researchers reveal the infectious impact of salmon farms on wild salmon
8. Researchers identify target for cancer drugs
9. Weill Cornell Research Reveals Secrets Of Trafficking Within Cells
10. Researchers discover molecule that causes secondary stroke
11. Researchers find missing genes of ancient organism
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/28/2016)... First quarter 2016:   , Revenues amounted ... quarter of 2015 The gross margin was 49% (27) ... the operating margin was 40% (-13) Earnings per share ... operations was SEK 249.9 M (21.2) , Outlook   ... M. The operating margin for 2016 is estimated to ...
(Date:4/15/2016)... -- Research and Markets has announced the ...  report to their offering.  ,      ... gait biometrics market is expected to grow at ... Gait analysis generates multiple variables such ... compute factors that are not or cannot be ...
(Date:3/29/2016)... LegacyXChange, Inc. (OTC: LEGX ... Protect are pleased to announce our successful effort to ... of writing instruments, ensuring athletes signatures against counterfeiting and ... athletes on LegacyXChange will be assured of ongoing proof ... Bill Bollander , CEO states, "By inserting ...
Breaking Biology News(10 mins):
(Date:4/28/2016)... India , April 28, 2016 ... JT, Stirling, and Brayton Cryocoolers), Service (Technical Support, Product ... and Geography - Global Forecast to 2022", published by ... USD 2.94 Billion by 2022, at a CAGR of ... 70 market data Tables and 94 Figures spread through ...
(Date:4/28/2016)... Windsor, Connecticut (PRWEB) , ... April 28, 2016 ... ... Morris Group, Inc., will hold an open house for regional manufacturers at its ... and displays from Tsugami, Okuma, Hardinge Group, Chiron and Trumpf. Almost 20 ...
(Date:4/27/2016)... British Columbia , April 27, 2016 /PRNewswire/ ... oder "NanoStruck") (CSE: NSK) (OTCPink: NSKQB) ( ... im Anschluss an ihre Pressemitteilung vom 13. August ... erhalten hat, ihre Finanzen um zusätzliche 200.000.000 Einheiten ... 4.000.000 Kanadische Dollar zu bringen. Davon wurden 157.900.000 ...
(Date:4/27/2016)... , ... April 27, 2016 , ... ... simultaneous preclinical PET (Positron Emission Tomography) and MRI (Magnetic Resonance Imaging) in existing ... disease and testing novel treatments in small animal subjects. Simultaneous PET/MRI imaging offers ...
Breaking Biology Technology: